SCHEMBL3207786

SCHEMBL3207786

CCOC(=O)Cc1cccc(N(Cc2cncs2)c2ccc(OC(F)F)c(OC(F)F)c2)c1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.35
CYP3A4 P08684 10/20 0.35
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
MAOB P27338 2/20 0.34
NPC1 O15118 1/20 0.34
PKM P14618 1/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HRH4 Q9H3N8 1/20 0.33
GRM2 Q14416 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218633 0.96 HRH4 (0.37) TRPM8CYP3A4PDE4APDE4BPDE4C
SCHEMBL3210508 0.92 TRPM8 (0.37) TRPM8CYP3A4PDE4APDE4BPDE4C
SCHEMBL3200782 0.88 PDE4A (0.39) CYP3A4PDE4APDE4BPDE4CPDE4D
SCHEMBL3129231 0.88 PDE4B (0.38) PDE4APDE4BPDE4CPDE4DMAOB
SCHEMBL3205713 0.87 HRH4 (0.38) TRPM8CYP3A4PDE4APDE4BPDE4C
SCHEMBL3129693 0.87 GRM2 (0.44) TRPM8PDE4BGRM2
SCHEMBL3193291 0.83 PCSK9 (0.39) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL3123327 0.81 PDE4A (0.38) PDE4APDE4BPDE4CPDE4D
SCHEMBL3203958 0.81 HRH4 (0.37) PDE4APDE4BPDE4CPDE4DMAOB
SCHEMBL3122279 0.80 ALDH1A1 (0.43) TRPM8PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B TRPM8 3474/4885CYP3A4 48/4885PDE4A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.